Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. AQST
AQST logo

AQST

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

AQST News

Class Action Notice for Aquestive Therapeutics Investors

23h agoGlobenewswire

Reminder of Class Action Lawsuit for Aquestive Securities

3d agoPRnewswire

Class Action Lawsuit Filed Against Aquestive Therapeutics

4d agoGlobenewswire

Faruqi & Faruqi Encourages Investors to Contact Regarding Aquestive Losses

4d agoPRnewswire

Class Action Lawsuit Filed Against Aquestive Therapeutics

5d agoGlobenewswire

Shareholder Alert for Aquestive Therapeutics

6d agoPRnewswire

Class Action Lawsuit Filed Against Aquestive Therapeutics

6d agoGlobenewswire

Reminder of Class Action for Aquestive Therapeutics Investors

Apr 13 2026Globenewswire

Aquestive Faces Class Action Over Delayed Drug Approval

Apr 13 2026Globenewswire

Class Action Notice for Aquestive Therapeutics Investors

Apr 11 2026PRnewswire

Notice of Class Action Lawsuit Against Aquestive Therapeutics

Apr 10 2026Globenewswire

AQST Shareholder Alert: False Statements Impact Stock Price

Apr 10 2026Globenewswire

Faruqi & Faruqi Encourages Investors to Contact Regarding Aquestive Losses

Apr 10 2026PRnewswire

Class Action Lawsuit Filed Against Aquestive Therapeutics

Apr 09 2026Globenewswire

Reminder of Class Action for Aquestive Therapeutics Investors

Apr 07 2026Globenewswire

Class Action Lawsuit Filed Against Aquestive Therapeutics

Apr 07 2026Globenewswire